Abstract: Methods and compositions for decentralized systems for mitigating climate change are provided. In some embodiments, the compositions comprise: one or more first servers operable to store a plurality of first tokens, wherein each one of the plurality of first tokens is associated with fiscal value; one or more second servers operable to store a plurality of second tokens, wherein each one of the plurality of second tokens corresponds to a unit of voting power; one or more project developer nodes operable to transmit project data corresponding to renewable energy or carbon sequestration; one or more auditor nodes operable to verify an identity, validate credentials, perform a project assessment, generate a smart contract, receive signals, and transmit signals; and one or more steward nodes, wherein each one of the one or more steward nodes is operable to stake tokens for voting power and to distribute voting power.

Abstract: A skate squaring device includes a main frame having a slot to receive a skate blade. The main frame is designed to attach to a portion of a skate sharpening fixture such that calibration lines on the main frame are perpendicular to a centerline axis of a body of the skate blade when mounted in the holder. A magnetic angle is attached to the end of the skate blade and positioned adjacent a face of the main frame having the calibration lines to determine if the skate blade edge is square.

Abstract: A skate sharpening holder includes an anvil plate surface that is adapted to engage with a skate blade so that the skate blade is securely held with respect to the anvil during skate sharpening or contouring. The anvil plate surface can include pins or openings that would engage with respective openings or pins in a skate blade to hold the skate blade in place.

Abstract: A skate sharpening holder includes an anvil plate surface that is adapted to engage with a skate blade so that the skate blade is securely held with respect to the anvil during skate sharpening or contouring. The anvil plate surface can include pins or openings that would engage with respective openings or pins in a skate blade to hold the skate blade in place.

Abstract: A skate squaring device includes a main frame having a slot to receive a skate blade. The main frame is designed to attach to a portion of a skate sharpening fixture such that calibration lines on the main frame are perpendicular to a centerline axis of a body of the skate blade when mounted in the holder. A magnetic angle is attached to the end of the skate blade and positioned adjacent a face of the main frame having the calibration lines to determine if the skate blade edge is square.

Abstract: Propargyl bromide is effectively stabilized against shock or thermal decomposition by use therewith of an environmentally acceptable inert liquid solvent that forms an azeotrope with propargyl bromide.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: Propargyl bromide is effectively stabilized against shock or thermal decomposition by use therewith of an environmentally acceptable inert liquid solvent that forms an azeotrope with propargyl bromide.

Abstract: Propargyl bromide is effectively stabilized against shock or thermal decomposition by use therewith of an environmentally acceptable inert liquid solvent that forms an azeotrope with propargyl bromide.

Abstract: Propargyl bromide is effectively stabilized against shock or thermal decomposition by use therewith of an environmentally acceptable inert liquid solvent that forms an azeotrope with propargyl bromide.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: Propargyl bromide is effectively stabilized against shock or thermal decomposition by use therewith of an environmentally acceptable inert liquid solvent that forms an azeotrope with propargyl bromide.

Abstract: A process for thermal benzylic bromination of a wide variety of benzylic compounds is described. Bromine is used as the bromination agent. Moderate temperatures are employed and the process can be used to produce in relatively pure form either mono- or dibrominated benzylic bromination products.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels.

Abstract: Architecturally aesthetic signage having a sufficient hardness that upon interaction with an etchent results in a plurality of smooth tiers or terraces resulting in both visual and tactile indicia for communication with an observer is disclosed. In the preferred embodiment, the tactile and visual indicia comply with the requirements of the Americans for Disabilities Act. The signage is preferably formed by an etcher system including: an etchent delivery; an etchent; a substrate holder; a substrate having sufficient hardness that upon interaction with the etchent produces the visual indicia for communication with an observer; and a controller for controlling the delivery of the etchent onto the substrate to form the signage.

Abstract: A method for orally administering vitamin preparations is described which combine vitamin B12 (B12, cobalamin) and folic acid (folate), with and without pyridoxine (B6), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B12 and/or folic acid deficiencies. Further, it is likely that a B6 deficiency may be present with a B12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. One embodiment of the invention is the use of a non-prescription formulation containing 2.0 mg B12 and 0.4 mg folic acid, with and without 25 mg B6. Another embodiment uses a prescription strength formulation containing 2.0 mg B12 and 1.0 mg folic acid, with and without 25 mg B6.

Abstract: The present invention is directed to an audio sign adapted to provide an aural message once the sign is tactilely actuated. The invention typically includes a graphical information section, a tactile information section, and a self contained audio section configured to provide aural information once tactilely actuated.